Clinical Trial: A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized Open Label Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).

Brief Summary:

Klebsiella pneumonia, inhabitant of the digestive tract, is a frequent nosocomial pathogen. It is currently the fourth most common cause of pneumonia and fifth most common cause of bacteremia in intensive care patients (1-3).

The aim of the present randomized controlled trial is to assess the efficacy of non-absorbable oral antibiotics in the eradication of the KPC carrier state.


Detailed Summary:
Sponsor: Rambam Health Care Campus

Current Primary Outcome: The specific measure that will be used to determine the effect of the intervention(s): eradication rate (%). [ Time Frame: twice a week ]

- Is this outcome measure assessing a safety issue? Select: no


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Rambam Health Care Campus

Dates:
Date Received: December 23, 2010
Date Started: July 2009
Date Completion:
Last Updated: April 26, 2017
Last Verified: April 2017